Status:
NOT_YET_RECRUITING
Immunity With Acute Hepatits A
Lead Sponsor:
Assiut University
Conditions:
Hepatitis A
Hepatitis A Virus
Eligibility:
All Genders
1-15 years
Brief Summary
Hepatitis A Virus (HAV) is a public health concern in Egypt, especially among children. Historically highly endemic, recent studies suggest a changing epidemiology. While improved socioeconomic condit...
Detailed Description
Introduction Hepatitis A virus (HAV) infection remains a significant public health concern in Egypt, particularly among children. Egypt has historically been considered an area of high endemicity for...
Eligibility Criteria
Inclusion
- Children aged 1-15 years
- Confirmed diagnosis of acute hepatitis A infection (positive anti-HAV IgM)
- Admitted to the hospital for management of acute hepatitis A
- Parental/guardian consent and child assent (where appropriate) obtained
Exclusion
- Known pre-existing liver disease or chronic hepatitis
- Immunodeficiency disorders or current immunosuppressive therapy
- Coinfection with other hepatotropic viruses (HBV, HCV, HEV)
- Severe malnutrition
- Recent blood transfusion (within 3 months)
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06942962
Start Date
October 1 2025
End Date
November 1 2026
Last Update
April 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.